Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of potent tubulin polymerization inhibitor with promising anticancer activity

June 8, 2022

Genuv and Nanocarry partner to treat metastatic tumors in the brain

June 7, 2022

Karolinska Development invests in PharmNovo to advance neuropathic pain treatment

June 7, 2022

Analysis of pain insensitivity disorder reveals new target for pain relief

June 7, 2022

BioVaxys reports progress in pan-sarbecovirus vaccine program

June 7, 2022

Novel fungal Hsp90 inhibitors for the treatment of azole-resistant candidiasis

June 7, 2022

Molecule "superglues" itself to enzyme to fight all stages of malaria parasite

June 7, 2022

Heme oxygenase-1-modified exosomes developed for temozolomide-resistant glioblastoma

June 7, 2022

TPI1 as a novel therapeutic target in breast cancer

June 7, 2022

New Bruton tyrosine kinase inhibitors identified at Biogen

June 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...